Clinicopathologic features and treatment outcomes in differentiated thyroid carcinoma patients with concurrent graves' disease.
Wed, 10/01/2008 - 03:00
This study aimed to identify the clinicopathologic features, treatment outcome, and the indicators for predicting recurrence, and to suggest the optimal extent of surgery in these patients. We retrospectively analyzed data of 58 patients who underwent surgical treatment for differentiated thyroid cancer and concurrent Graves' disease. The follow-up period ranged from 23 to 260 months (mean+/-standard devuation, 116.8+/-54.0). In our series, the mean age was 40.8+/-12.7 yr (range, 15-70), with a male-to-female ratio of 1: 6.25. The mean tumor size was 13+/-9 mm (range, 3-62). The surgical methods included 19 cases of total thyroidectomy, 38 cases of subtotal thyroidectomy, and 1 case of completion total thyroidectomy. Locoregional recurrence occurred in four patients (6.9%). The 10-yr overa... MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.
- Original article
- Login or register to post comments



Tuesday February 07, 2012
10:24 pm













